Weekend Versus Weekday Mortality for Thrombotic Thrombocytopenic Purpura (TTP) Related Hospitalizations in the United States: Data from the National Inpatient Sample

Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 4863-4863
Author(s):  
Smith Giri ◽  
Ranjan Pathak ◽  
Madan Raj Aryal ◽  
Paras Karmacharya ◽  
Michael G Martin

Abstract Introduction: Previous research has shown that weekend hospital admissions are associated with an increased mortality in comparison to weekday admissions for a number of emergent conditions including myocardial infarction [Relative Risk (RR) 1.048; 95% confidence interval [CI], 1.022 to 1.076; P value <0.001], pulmonary embolism (RR 1.17, 95% CI 1.03 to 1.34, P value <0.01) and gastrointestinal hemorrhage (RR 1.17, 95% CI 1.03 to 1.34, P value <0.01) . Thrombotic Thrombocytopenic Purpura (TTP) is a hematological emergency with a significant morbidity and mortality if not recognized early. However, studies evaluating if a similar "weekend" effect exists in TTP are lacking. Methods: We used the Nationwide Inpatient Sample database to identify patients admitted with TTP in the United States using ICD 9 CM code 446.6 from 2009 to 2011. Baseline data for demographic variables, age, gender, race, hospital characteristics- region, hospital type (rural versus urban, teaching versus non-teaching), bed-size, insurance payer and comorbidities were derived for weekend and weekday admissions. Logistic regression analysis was used to calculate the adjusted relative risk of in-hospital mortality of weekend versus weekday admissions. Data analysis was done using STATA 13.0 (College Station, TX: StataCorp LP) Results: Of the 6634, estimated TTP related hospitalizations, 19.5 % were admitted on the weekends and 80.5 % admitted on the weekdays. The mean age was 48±0.5 years and 66.4 % were females. A higher in-hospital mortality rate was seen among weekend admissions as compared to weekday admissions (RR 1.32, 95% CI 1.30-1.33, p value <0.01). On multivariate analysis (table 1), weekend admission remained as an independent predictor of increased mortality (adjusted RR 1.16, 95% CI 1.15-1.17, P value <0.01) after adjusting for other confounders including age, gender, comorbidities, hospital type and size. Similarly, acute kidney injury (adjusted RR 3.41, 95% CI 3.34-3.43, P value <0.001), stroke (adjusted RR 5.46, 95% CI 5.31-5.62, P value <0.001), and sepsis (adjusted RR 6.57, 95% CI 6.40-6.75, Pvalue <0.001) were associated with significantly increased risk of mortality among patients with TTP (table 1). Conclusions: A significantly higher in-hospital mortality occurs among TTP patients admitted on the weekends as compared to weekdays. Future research should focus on identifying the underlying factors for this difference so that quality improvement measures could be taken to mitigate this difference. Table 1: Logistic Regression Analysis showing the adjusted relative risk (RR) of various patient and hospital characteristics in predicting in-hospital mortality for patients with TTP. Variable Adjusted RR 95% CI of Adjusted RR P value Weekend admission 1.16 1.15-1.17 <0.001 Pay - Medicare - Medicaid - Private including HMO - self-pay - no charge - other 1.0 1.33 1.19 1.63 1.36 2.02 .. 1.28-1.38 1.14-1.25 1.50-1.77 1.11-1.67 1.73-2.36 <0.001 <0.001 <0.001 <0.001 <0.001 Race - white - black - hispanic - asian or pacific islander - native american - other 1.0 1.01 0.93 1.13 1.05 1.07 0.98-1.03 0.89-0.97 1.07-1.19 0.94-1.16 1.02-1.13 0.47 0.003 <0.001 0.34 0.003 Region - Northeast -Midwest - South - West 1 0.92 1.05 0.97 0.86-0.98 0.99-1.11 0.91-1.04 0.01 0.06 0.48 Co-morbidities - smoking - obesity - dyslipidemia - hypertension - diabetes mellitus - peripheral vascular disease - coronary artery disease - acute kidney injury - chronic kidney disease - stroke - sepsis 0.90 0.78 0.60 0.68 0.99 1.32 1.06 3.41 1.10 5.46 6.57 0.88-0.92 0.76-0.79 0.59-0.61 0.67-0.69 0.97-1.00 1.29-1.34 1.05-1.07 3.34-3.43 1.08-1.11 5.31-5.62 6.40-6.75 <0.001 <0.001 <0.001 <0.001 0.12 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 Age 1.04 1.043-1.046 <0.001 Female 0.78 0.78-0.79 <0.001 Hospital Type - rural - urban non teaching - urban teaching 1.0 0.92 1.05 0.88-0.97 0.99-1.11 0.002 0.061 Bed size - small - medium - large 0.95 1.01 0.89-1.01 0.96-1.07 0.11 0.51 Disclosures No relevant conflicts of interest to declare.

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Jeremiah R. Brown ◽  
Michael E. Rezaee ◽  
Emily J. Marshall ◽  
Michael E. Matheny

Acute kidney injury (AKI) is a common reason for hospital admission and complication of many inpatient procedures. The temporal incidence of AKI and the association of AKI admissions with in-hospital mortality are a growing problem in the world today. In this review, we discuss the epidemiology of AKI and its association with in-hospital mortality in the United States. AKI has been growing at a rate of 14% per year since 2001. However, the in-hospital mortality associated with AKI has been on the decline starting with 21.9% in 2001 to 9.1 in 2011, even though the number of AKI-related in-hospital deaths increased almost twofold from 147,943 to 285,768 deaths. We discuss the importance of the 71% reduction in AKI-related mortality among hospitalized patients in the United States and draw on the discussion of whether or not this is a phenomenon of hospital billing (coding) or improvements to the management of AKI.


2021 ◽  
Author(s):  
Steven L. Flamm ◽  
Kimberly Brown ◽  
Hani M. Wadei ◽  
Robert S. Brown ◽  
Marcelo Kugelmas ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-2 ◽  
Author(s):  
Rishika Singh ◽  
Dilip R. Patel ◽  
Sherry Pejka

Rhabdomyolysis can occur because of multiple causes and account for 7% of all cases of acute kidney injury annually in the United States. Identification of specific cause can be difficult in many cases where multiple factors could potentially cause rhabdomyolysis. We present a case of 16-year-old male who had seizures and was given levetiracetam that resulted in rhabdomyolysis. This side effect has been rarely reported previously and like in our case diagnosis may be delayed.


Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 14-14
Author(s):  
Yan Cheng ◽  
Sharif Mohammed ◽  
Alexis Okoh ◽  
Ki (Steve) Lee ◽  
Corinne Raczek ◽  
...  

Introduction: Early studies from Wuhan, China have reported an association between blood type and outcomes in COVID-19 infected patients. Conflicting reports in literature have investigated the protective role of blood type O against worst outcomes associated with COVID-19 infections. Approximately 50% of Black/African Americans (AA) have blood group O. Our study is the only study to date looking at the association between Black/AA and blood type. We aimed to determine the association between blood type and Black/AA patients hospitalized for COVID-19. Methods: We retrospectively reviewed data on patients with known blood type, who were admitted for COVID-19 at a single center between March and April 2020. We excluded other races in our study because only about 2% of the population was Caucasian and 8% representing other races, representing a small subset of patients under study whereas Black/AA represented about 90% of our hospitalized patients. Patients were stratified into 4 groups based on their ABO blood type. Baseline demographic, clinical characteristics and clinical course of the disease were compared. The primary end point was in-hospital mortality. Secondary endpoints included admission to the intensive care unit (ICU), acute kidney injury requiring hemodialysis and length of stay (LOS). Results: During the study period, a total of 256 patients were reviewed. Distribution of ABO type was as follows; A: (N=65) 25%, B: (N=62) 24%, AB: (N=9) 4%, O: (N=120) 47%. Compared to blood types A, B and O, AB patients were younger (mean; yrs. 63 vs. 63 vs. 62 vs. 43 yrs. p=0.0242). Blood type B patients were more likely to present with nausea, than groups A, AB, and O. (27% vs. 10% vs. 0% vs. 5%; p=0.017). All other characteristics including baseline inflammatory markers were comparable. There was no difference among groups regarding in-hospital mortality (A: 39% B: 29% AB: 33% O: 31% p value: 0.676) or admission to the ICU (A:31% B: 28% AB: 33% O: 34% p value: 0.840). The incidence of acute kidney injury requiring hemodialysis was higher in blood type A patients compared to B, AB, and O. (31% vs. 0% vs. 23% vs. 19%; p=0.046). In hospital LOS was comparable among all groups. Conclusions: In this single center analysis of black/AA patients admitted for COVID-19, there was no association between blood type and in-hospital mortality or admission to ICU. Blood type A patients had a higher propensity of kidney injury, but this did not translate into worse in-hospital survival. Disclosures Cohen: GBT: Speakers Bureau.


2019 ◽  
Vol 9 (12) ◽  
pp. 933-941 ◽  
Author(s):  
Christina Bradshaw ◽  
Jialin Han ◽  
Glenn M. Chertow ◽  
Jin Long ◽  
Scott M. Sutherland ◽  
...  

Author(s):  
Charat Thongprayoon ◽  
Tananchai Petnak ◽  
Wisit Kaewput ◽  
Fawad Qureshi ◽  
Michael A. Mao ◽  
...  

2016 ◽  
Vol 10 (3) ◽  
pp. 525-531 ◽  
Author(s):  
Girish N. Nadkarni ◽  
Priya K. Simoes ◽  
Achint Patel ◽  
Shanti Patel ◽  
Rabi Yacoub ◽  
...  

2017 ◽  
Vol 5 (4) ◽  
pp. 232470961774619
Author(s):  
Pooja Sethi ◽  
Jennifer Treece ◽  
Chidinma Onweni ◽  
Vandana Pai ◽  
Sowminya Arikapudi ◽  
...  

Untreated human immunodeficiency virus (HIV) can be complicated by opportunistic infections, including disseminated histoplasmosis (DH). Although endemic to portions of the United States and usually benign, DH can rarely act as an opportunistic infection in immunocompromised patients presenting with uncommon complications such as acute kidney injury and idiopathic thrombocytopenic purpura. We report a rare presentation of DH presenting with acute kidney injury and immune thrombocytopenic purpura in an immunocompromised patient with HIV.


2012 ◽  
Vol 15 (4) ◽  
pp. A154
Author(s):  
B. Hopkins ◽  
E. Obi-tabot ◽  
H. Wang ◽  
Y. Wang ◽  
T. Blount ◽  
...  

2016 ◽  
Vol 43 (4) ◽  
pp. 261-270 ◽  
Author(s):  
Jeremiah R. Brown ◽  
Michael E. Rezaee ◽  
William M. Hisey ◽  
Kevin C. Cox ◽  
Michael E. Matheny ◽  
...  

Background: Dialysis-requiring acute kidney injury (AKI-D) is a documented complication of hospitalization and procedures. Temporal incidence of AKI-D and related hospital mortality in the US population has not been recently characterized. We describe the epidemiology of AKI-D as well as associated in-hospital mortality in the US. Methods: Retrospective cohort of a national discharge data (n = 86,949,550) from the Healthcare Cost and Utilization Project's National Inpatient Sample, 2001-2011 of patients' hospitalization with AKI-D. Primary outcomes were AKI-D and in-hospital mortality. We determined the annual incidence rate of AKI-D in the US from 2001 to 2011. We estimated ORs for AKI-D and in-hospital mortality for each successive year compared to 2001 using multiple logistic regression models, adjusted for patient and hospital characteristics, and stratified the analyses by sex and age. We also calculated population-attributable risk of in-hospital mortality associated with AKI-D. Results: The adjusted odds of AKI-D increased by a factor of 1.03 (95% CI 1.02-1.04) each year. The number of AKI-D-related (19,886-34,195) in-hospital deaths increased almost 2-fold, although in-hospital mortality associated with AKI-D (28.0-19.7%) declined significantly from 2001 to 2011. Over the same period, the adjusted odds of mortality for AKI-D patients were 0.60 (95% CI 0.56-0.67). Population-attributable risk of mortality associated with AKI-D increased (2.1-4.2%) over the study period. Conclusions: The incidence rate of AKI-D has increased considerably in the US since 2001. However, in-hospital mortality associated with AKI-D hospital admissions has decreased significantly.


Sign in / Sign up

Export Citation Format

Share Document